Daiichi Sankyo & Merck voluntarily withdraws patritumab deruxtecan BLA to treat locally advanced or metastatic EGFR-mutated NSCLC from US FDA: Basking Ridge, New Jersey Friday, Ma ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.